Description
Open-label Phase 2, Randomized, Controlled MulticenterStudy Comparing Niraparib Versus Platinum-taxane Doublet Chemotherapy asNeoadjuvant Treatment in Participants with Homologous recombination-deficientStage III/IV Ovarian Cancer
Location: CPMC (San Francisco)
Please contact: ClinicalResearch@sutterhealth.org about study OPAL Cohort C